Search Results - "Verboom, P."

Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use by Kerremans, J. J., Verboom, P., Stijnen, T., Hakkaart-van Roijen, L., Goessens, W., Verbrugh, H. A., Vos, M. C.

“…Introduction Rapid bacterial identification and susceptibility tests can lead to earlier microbiological diagnosis and pathogen-directed, appropriate therapy…”
Get full text

The cost of atopic dermatitis in the Netherlands: an international comparison by Verboom, P., Hakkaart-Van Roijen, L., Sturkenboom, M., De Zeeuw, R., Menke, H., Rutten, F.

“…Summary Background Only a few international studies have assessed the economic burden of atopic dermatitis (AD), and no costs‐of‐illness study for AD has been…”
Get full text

Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin by Touw, C.R., Hakkaart-Van Roijen, L., Verboom, P., Paul, C., Rutten, F.F.H., Finlay, A.Y.

“…Background Psoriasis causes considerable patient morbidity and can seriously affect a patient’s quality of life (QoL). Objectives To investigate the…”
Get full text

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits by Uyl-de Groot, C.A., Vermorken, J.B., Hanna, M.G., Verboom, P., Groot, M.T., Bonsel, G.J., Meijer, C.J.L.M., Pinedo, H.M.

“…We have completed a multicenter, randomized controlled phase III clinical trial in Stages II and III colon cancer patients with active specific immunotherapy…”
Get full text

Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: The PLUS study by VERBOOM, Paul, VAN TINTEREN, Harm, VAN MOURIK, Johan C, POSTMUS, Pieter E, BOERS, Maarten, GRIJSEELS, Els W. M, TEULE, Gerrit J. J, UYL-DE GROOT, Carin A, HOEKSTRA, Otto S, SMIT, Egbert F, VAN DEN BERGH, Jan H. A. M, SCHREURS, Ad J. M, STALLAERT, Roland A. L. M, VAN VELTHOVEN, Piet C. M, COMANS, Emile F. I, DIEPENHORST, Fred W

“…Currently, up to 50% of the operations in early-stage non-small cell lung cancer (NSCLC) are futile owing to the presence of locally advanced tumour or distant…”
Get full text

Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals by Herder, G J M, Verboom, P, Smit, E F, van Velthoven, P C M, van den Bergh, J H A M, Colder, C D, van Mansom, I, van Mourik, J C, Postmus, P E, Teule, G J J, Hoekstra, O S

“…Background: A study was undertaken to investigate the clinical practice, yield, and costs of preoperative staging in patients with suspected NSCLC and to…”
Get full text

The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasis by Hakkaart-van Roijen, L, Verboom, P, Redekop, W K, Touw, K R, Rutten, F F

“…To assess the cost effectiveness of tapered versus abrupt discontinuation of a microemulsion formulation of cyclosporin in patients with chronic plaque…”
Get full text

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial by van Tinteren, Harm, Hoekstra, Otto S, Smit, Egbert F, van den Bergh, Jan HAM, Schreurs, Ad JM, Stallaert, Roland ALM, van Velthoven, Piet CM, Comans, Emile FI, Diepenhorst, Fred W, Verboom, Paul, van Mourlk, Johan C, Postmus, Pieter E, Boers, Maarten, Teule, Gerrit JJ

“…Up to 50% of curative surgery for suspected non-small-cell lung cancer is unsuccessful. Accuracy of positron emission tomography (PET) with…”
Get full text

Traditional Versus Up-Front [18F] Fluorodeoxyglucose–Positron Emission Tomography Staging of Non–Small-Cell Lung Cancer: A Dutch Cooperative Randomized Study by HERDER, Gerarda J. M, KRAMER, Henk, PAUL, Marinus A, BOERS, Maarten, POSTMUS, Pieter E, TEULE, Gerrit J, GROEN, Harry J. M, HOEKSTRA, Otto S, SMIT, Egbert F, PRUIM, Fan, VAN TINTEREN, Harm, CANTANS, Emile F, VERBOOM, Paul, UYL-DE GROOT, Carin A, WELLING, Alle

“…We investigated whether application of positron emission tomography (PET) immediately after first presentation might simplify staging while maintaining…”
Get full text

A long InGaAsP/InP waveguide section with small dimensions by Verboom, P., Oei, Y.S., Pennings, E., Smit, M., van Uffelen, J., van Brug, H., Moerman, I., Coudenijs, G., Demeester, P.

“…A spirally folded InGaAsP/InP ridge-type waveguide with 12.4 mm length, corresponding to 4-cm free-space length, on a device area of 1 mm*1 mm, was realized…”
Get full text

The cost effectiveness of Apligraf® Treatment of Diabetic foot ulcers by REDEKOP, W. Ken, MCDONNELL, Joseph, VERBOOM, Paul, LOVAS, Kornelia, KALO, Zoltan

“…Diabetic foot ulcers (DFUs) present a treatment challenge and result in a large economic burden, requiring careful evaluation of the clinical efficacy and cost…”
Get full text

Het valutabeleid in de internationale onderneming by Verboom, P. M.

Get full text

PDG15: THE COST OF TREATING DIABETIC FOOT ULCERS (DFU) WITH APLIGRAF IN THE NETHERLANDS by McDonnell, J, Redekop, K, Verboom, P, Lovas, K, Kalo, Z

Get full text

Randomized controlled trial (RCT) to evaluate the cost-effectiveness of positron emission tomography (PET) added to conventional diagnostic strategies in non-small cell lung cancer (NSCLC) by van Tinteren, H, Hoekstra, O.S, Verboom, P, Smit, E.F

Get full text

CN3 IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR CELL-BCG VACCINE (ONCOVAX®) IN PATIENTS WITH STAGE II COLON CANCER: MEDICAL AND ECONOMIC BENEFITS by Uyl-de Groot, CA, Hanna, MG, Groot, MT, Verboom, P, Hoover, HC, Vermorken, JB

Get full text

Zijn financieel beleid en valutabeleid van elkaar te scheiden? by Van Den Bergh, W. M., Verboom, P. M.

Get full text

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial by van Tinteren, H, Hoekstra, O S, Smit, E F, van den Bergh, J H A M, Schreurs, A J M, Stallaert, R A L M, van Velthoven, P C M, Comans, E F I, Diepenhorst, F W, Verboom, P, van Mourik, J C, Postmus, P E, Boers, M, Teule, G J J

“…Up to 50% of curative surgery for suspected non-small-cell lung cancer is unsuccessful. Accuracy of positron emission tomography (PET) with…”
Get full text

Staging of non-small-cell lung cancer and application of FDG-PET. A cost modeling approach by Verboom, Paul, Herder, G Judith M, Hoekstra, Otto S, Smit, Egbert F, van den Bergh, Jan H A M, van Velthoven, Piet C M, Grijseels, Els W M

“…The presence of (distant) metastases affects the therapy (operation) and prognosis of patients with non-small-cell lung cancer (NSCLC). Fifty percent of the…”
Get more information

Toward Less Futile Surgery in Non-Small Cell Lung Cancer? A Randomized Clinical Trial to Evaluate the Cost-Effectiveness of Positron Emission Tomography by van Tinteren, Harm, Hoekstra, Otto S., Smit, Egbert F., Verboom, Paul, Boers, Maarten

“…Non-small cell lung cancer can be cured if the patient is medically operable and the tumor resectable. Current diagnostic strategies are aimed to detect tumor…”
Get full text